David Arons

David Arons

Company: National Brain Tumor Society

Job title: Chief Executive Officer


Panel Discussion: GBM AGILE Goes Worldwide: Taking a Deep Dive Into How Well It Has Worked So Far & What Promise It Brings With Expansion 9:00 am

Reflecting on more than 3 years of progress – lessons learned to date and plans/goals for the next 3+ years Stakeholder perspectives – industry, clinical/scientific investigators, and patient advocates Adaptive Global Innovative Learning Environment (AGILE): Focusing on the “LE” in AGILERead more

day: Conference Day One

Panel Discussion: Navigating the Catch-22 With GBM Funding: How Can Investors & Companies Work Together to Solve This Dilemma?
Moderated by: Scott Rakestraw 9:30 am

Addressing how to attract investment for the indication that the proposition has not yet been clinically proven Discussing gaining support for novel strategies, including combination trials especially when monotherapy has not been proven in isolation Evaluating preclinical models in their reliability to reflect clinical outcomes and which models appeal to investors the most Comparing the…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.